Berend Arnold Ploeger
LAP&P Consultants BV
Leiden
Netherlands
Name/email consistency: high
- Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex. Ploeger, B.A., Smeets, J., Strougo, A., Drenth, H.J., Ruigt, G., Houwing, N., Danhof, M. Anesthesiology (2009)
- Washout and delayed start designs for identifying disease modifying effects in slowly progressive diseases using disease progression analysis. Ploeger, B.A., Holford, N.H. Pharm. Stat (2009)
- Incorporating receptor theory in mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling. Ploeger, B.A., van der Graaf, P.H., Danhof, M. Drug Metab. Pharmacokinet. (2009)
- The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. Ploeger, B., Mensinga, T., Sips, A., Seinen, W., Meulenbelt, J., DeJongh, J. Drug Metab. Rev. (2001)
- A human physiologically-based model for glycyrrhzic acid, a compound subject to presystemic metabolism and enterohepatic cycling. Ploeger, B., Mensinga, T., Sips, A., Meulenbelt, J., DeJongh, J. Pharm. Res. (2000)
